4.7 Article

Repurposing thioridazine for inducing immunogenic cell death in colorectal cancer via eIF2 & alpha;/ATF4/CHOP and secretory autophagy pathways

期刊

CELL COMMUNICATION AND SIGNALING
卷 21, 期 1, 页码 -

出版社

BMC
DOI: 10.1186/s12964-023-01190-5

关键词

Colorectal cancer; Thioridazine; Immunogenic cell death; Endoplasmic reticulum stress; Secretory autophagy

向作者/读者索取更多资源

In this study, it was found that the antipsychotic drug thioridazine (THD) could induce autophagy and immunogenic cell death (ICD) in colorectal cancer (CRC) cells. When combined with oxaliplatin (OXA), THD showed a remarkable ICD-activating effect to prevent tumor progression in a mouse model.
Background Colorectal cancer (CRC) is a highly prevalent cancer type with limited targeted therapies available and 5-year survival rate, particularly for late-stage patients. There have been numerous attempts to repurpose drugs to tackle this problem. It has been reported that autophagy inducers could augment the effect of certain chemotherapeutic agents by enhancing immunogenic cell death (ICD).Methods In this study, we employed bioinformatics tools to identify thioridazine (THD), an antipsychotic drug, and found that it could induce autophagy and ICD in CRC. Then in vitro and in vivo experiments were performed to further elucidate the molecular mechanism of THD in CRC.Results THD was found to induce endoplasmic reticulum (ER) stress in CRC cells by activating the eIF2a/ATF4/CHOP axis and facilitating the accumulation of secretory autophagosomes, leading to ICD. In addition, THD showed a remarkable ICD-activating effect when combined with oxaliplatin (OXA) to prevent tumor progression in the mouse model.Conclusions Together, our findings suggest that the repurposed function of THD in inhibiting CRC involves the upregulation of autophagosomes and ER stress signals, promoting the release of ICD markers, and providing a potential candidate to enhance the clinical outcome for CRC treatment.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据